BOB(SH:601169) Shang Hai Zheng Quan Bao·2025-12-09 23:10Group 1 - The National Healthcare Security Administration released the "Commercial Health Insurance Innovative Drug Catalog (2025)", which includes five CAR-T cell therapies, with the product from Huyuan Biotech, Nakiolunase Injection (Yuanruida®), being one of them [2] - CAR-T therapy involves genetically modifying T lymphocytes to express specific chimeric antigen receptors, enabling them to target and kill tumor cells, providing hope for over 300 patients when traditional chemotherapy fails [2][3] - Huyuan Biotech's Nakiolunase Injection (Yuanruida®) has a high clinical cure rate for adult acute lymphoblastic leukemia, which has a relapse rate of 60% and a median survival of only 2 to 6 months under traditional chemotherapy [3] Group 2 - Huyuan Biotech was founded in 2018 and collaborated with the Chinese Academy of Medical Sciences to develop a unique HI19a sequence structure embedded in CAR-T cells for precise tumor targeting [3] - The company received approval from the National Medical Products Administration for its first core product, Nakiolunase Injection (Yuanruida®), in 2023, establishing a solid foundation for drug accessibility through its self-developed production process and quality control system [3] - Beijing Bank's Tianjin branch provided critical financial support to Huyuan Biotech, customizing a financing plan that included a 10 million yuan credit loan to support CAR-T drug production [4][6] Group 3 - Huyuan Biotech's CEO expressed gratitude for the financial support from Beijing Bank, which enabled the company to invest more in research and production despite the unique challenges of the biotech industry [5] - Beijing Bank's lending strategy has evolved to focus on the technological barriers, patents, research teams, and shareholder backgrounds of biotech firms, rather than solely on financial statements [6] - The bank aims to enhance its service offerings for technology-driven companies, with a focus on innovative financing solutions and building a sustainable technology finance ecosystem [6][7]